Beyond Air, Inc.: The Biopharmaceutical Giant Developing LungFit Platform for COVID-19 Treatment Garden City-based commercial medical device and biopharmaceutical company, Beyond Air, Inc. has been a major player in the healthcare industry. Best known for its development of the innovative LungFit platform, a nitric oxide generator and delivery system, the company is making waves in the field of respiratory treatment. Its latest product, LungFit PRO, is currently under development as a potential treatment for viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients. Additionally, Beyond Air, Inc. also offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. before changing its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is poised to revolutionize respiratory treatment and improve patient outcomes.